Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Ramakrishnan, Sanjay; V. Nicolau, Dan; Langford, Beverly; Mahdi, Mahdi; Jeffers, Helen; Mwasuku, Christine; Krassowska, Karolina; Fox, Robin; Binnian, Ian; Glover, Victoria; Bright, Stephen; Butler, Christopher; Cane, Jennifer; Halner, Andreas; C. Matthews, Philippa; Donnelly, Louise; L. Simpson, Jodie; Baker, Jonathan; T. Fadai, Nabil; Peterson, Stefan; Bengtsson, Thomas; J. Barnes, Peter; Russell, Richard; Bafadhel, Mona

doi:10.1101/2021.02.04.21251134

Public

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Published in medRxiv • Feb 8, 2021

Authors:

Sanjay Ramakrishnan

Dan V. Nicolau

Beverly Langford

Abstract

Abstract Background Multiple early hospital cohorts of coronavirus disease 2019 (COVID-19) showed that patients with chronic respiratory disease were significantly under-represented. We hypothesised that the widespread use of inhaled glucocorticoids was responsible for this finding and tested if inh...

Subject

Medicine

Budesonide

Population

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!